AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 1,538 | 16,706 | 1,116 | 765 | 1,998 |
| Gross Profit | 1,538 | 16,706 | 1,116 | 765 | 1,998 |
| Operating Expenses | 13,484 | 13,408 | 11,135 | 9,146 | 9,803 |
| Operating Income | -11,946 | 3,298 | -10,019 | -8,381 | -7,804 |
| Interest Expense | 297 | -2,051 | 11 | 4,533 | 1,628 |
| Other Income | -12 | -1,115 | 892 | 396 | 13 |
| Pre-tax Income | -12,254 | 4,234 | -9,139 | -12,518 | -9,419 |
| Net Income Continuous | -12,254 | 4,234 | -9,139 | -12,518 | -9,419 |
| Net Income | $-12,254 | $4,234 | $-9,139 | $-12,518 | $-9,419 |
| EPS Basic Total Ops | -0.21 | 0.08 | -0.16 | -0.22 | -0.17 |
| EPS Basic Continuous Ops | -0.21 | 0.07 | -0.16 | -0.22 | -0.17 |
| EPS Diluted Total Ops | -0.21 | 0.08 | -0.16 | -0.22 | -0.17 |
| EPS Diluted Continuous Ops | -0.21 | 0.07 | -0.16 | -0.22 | -0.17 |
| EBITDA(a) | $-11,738 | $3,471 | $-9,848 | $-8,235 | $-7,706 |